Drug Carrier

D-tocopheryl polyethylene glycol succinate (Vitamin E TPGS) has been approved as a safe pharmaceutical adjuvant by FDA, and several drug...

The production of nanosuspensions of poorly soluble active pharmaceutical ingredients (API) is a popular technique to counteract challenges regarding bioavailability...

Bacterial immunity to antibiotics is currently increasing as a result of inadequate drug use and the generation of antimicrobial resistance....

Osteoarthritis (OA) is a prevalent degenerative disease that has a significant impact on patients' lives. Celecoxib (CXB) is now primarily used to treat OA with...

A significant proportion of pharmaceuticals are now considered multiparticulate systems. Modified-release drug delivery formulations can be designed with engineering precision,...

The solubility of a drug is higher when it is in an amorphous form than when it is in a...

Integrated API and drug product processing enable molecules with high clinical efficacy but poor physicochemical characteristics to be commercialized by...

Powders for nasal delivery have been recognized as advantageous dosage forms over liquids due to increased stability and residence time...

A novel approach for preparing drug-containing particles (DCPs) with controlled size distribution and high drug loading was developed using melt...

Dry powder inhalation offers a well-established administration route for either local or systemic drug delivery. Lactose-based powder blends still build...